biologics plant

Lonza to expand ADC capacity, broaden collab with US drugmaker

Lonza said that it will expand its capacity to produce ADC drugs. The CDMO also has increased the scope of its partnership with an unnamed U.S. drugmaker

Kevin Dunleavy Jul 1, 2026 3:22pm

AI manufacturing research RD technology digitalization

Manufacturing hurdles stifle launches as biologics gain steam

May 15, 2026 9:20am

Amgen adds $300M to US investment plan, targeting Puerto Rico

May 4, 2026 9:00am

UCB unveils plan to build $2B biologics plant in Georgia

Mar 24, 2026 2:56pm

Gilead breaks ground on production hub as part of $32B US outlay

Sep 3, 2025 2:36pm

UCB touts plan for 'major' US manufacturing investment

Jun 12, 2025 1:34pm